Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
350
NCT06550037
Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive Tool
Phase: N/A
Role: Collaborator
Start: Aug 7, 2023
Completion: May 31, 2027